A new acting FDA commissioner named: Ned Sharpless the National Cancer Institute Director
After the resignation of FDA Commissioner Scott Gottlieb was announced last week, Ned Sharpless (National Cancer Institute Director) will serve as acting FDA Commissioner, according to Health and Human Services Secretary Alex Azar. The administration is currently searching for a permanent replacement, Azar told the House Energy & Commerce Health Subcommittee Hearing. "It will be an honor to advance the FDA's critical public health mission and build on its progress toward the priorities laid out by President Trump, Secretary Azar, and Commissioner Gottlieb alongside the leadership and staff of the agency," Sharpless said in a statement. "There will be no let-up in the agency's focus, from ongoing efforts on drug approvals and combating the opioid crisis to modernizing food safety and addressing the rapid rise in youth use of e-cigarettes," Azar said in a statement. "Dr. Sharpless shares our mission and I know he will be embraced warmly by the Agency's professional staff," Gottlieb said. @ https://www.cnbc.com/2019/03/12/national-cancer-institute-director-ned-sharpless-will-be-acting-fda-commissioner.html" rel="nofollow noopener noreferrer" target="_blank">https://www.cnbc.com/2019/03/12/national-cancer-institute-director-ned-sharpless-will-be-acting-fda-commissioner.html
National Cancer Institute Director Ned Sharpless named acting FDA commissioner
National Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.